A. Nitta

(3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

A. Nitta, H. Fujii, Satoshi Sakami et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 35 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Medicine +10

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors

A. Nitta, H. Fujii, Satoshi Sakami et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 21 citations · Full text

Medicinal Chemistry, Novel Series, Biochemistry +9

Discovery and structure–activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2

Nobuhiro Fuchi, Yosuke Iura, H. Kaneko et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 20 citations

2,6-Disubstituted Pyrazines, Molecular Pharmacology, Medicinal Chemistry +13

Synthetic Study of Pinnatoxin A: Intramolecular Alkylation Approach to the G-ring

A. Nitta, Akihiro Ishiwata, Takeshi Noda et al. · Synlett · 1999 · 19 citations

Combinatorial Chemistry, Enantioselective Synthesis, Bioorganic Chemistry +14

HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models

Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 18 citations